Empagliflozin (EMPA) Compared with Glimepiride (GLIM) as Add-on to Metformin (MET) for 2 Years in Patients with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Ridderstrale, Martin
Andersen, Knut Robert
Zeller, Cordula
Kim, Gabriel
Woerle, Hans J.
Broedl, Uli C.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
266-OR
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
  • [21] HbA1c Response to Open-Label (OL) Empagliflozin (EMPA) with Metformin (MET) in Patients with Type 2 Diabetes (T2DM)
    Schernthaner, Guntram
    Tinahones, Francisco J.
    Goetz, Sophia
    Lee, Christopher
    DIABETES, 2017, 66 : A345 - A346
  • [22] Empagliflozin as Add-on to Linagliptin and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Region in a 24-Week Randomized Trial
    Wanner, Christoph
    Naderali, Ebrahim
    Maldonaldo, Mario
    Del Parigi, Angelo
    Toorawa, Robert
    Lee, Christopher
    DIABETES, 2016, 65 : A288 - A289
  • [23] Empagliflozin (EMPA) as add-on to linagliptin (LINA) and metformin in patients with type 2 diabetes (T2DM): a 24-week randomised, double-blind, parallel-group trial
    Maldonado-Lutomirsky, M.
    Softeland, E.
    Meier, J. J.
    Vangen, B.
    Toorawa, R.
    Woerle, H. -J.
    Broedl, U. C.
    DIABETOLOGIA, 2016, 59 : S93 - S93
  • [24] Empagliflozin as add-on to metformin in people with Type 2 diabetes
    Merker, L.
    Haering, H-U.
    Christiansen, A. V.
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 (12) : 1555 - 1567
  • [25] Empagliflozin as add-on to metformin plus sulfonylurea in patients with Type 2 diabetes
    Haering, H. U.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [26] Empagliflozin as add-on to pioglitazone with or without metformin in patients with Type 2 diabetes
    Kovacs, C. S.
    Seshiah, V.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Stella, P.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 88 - 88
  • [27] Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes
    Haering, Hans-Ulrich
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (01) : 82 - 90
  • [28] Linagliptin (LINA) as add-on to empagliflozin (EMPA) and metformin in patients with type 2 diabetes (T2DM): two 24-week randomised, double-blind, parallel-group trials
    Tinahones, F. J.
    Gallwitz, B.
    Nordaby, M.
    Goetz, S.
    Maldonado-Lutomirsky, M.
    Woerle, H. -J.
    Broedl, U. C.
    DIABETOLOGIA, 2016, 59 : S371 - S372
  • [29] Empagliflozin as Add-on to Linagliptin and Metformin in Patients with Type 2 Diabetes (T2DM): Subgroup Analysis by Baseline Demographics in a 24-Week Randomized Trial
    Seufert, Jochen
    Naderali, Ebrahim
    Maldonaldo, Mario
    Del Parigi, Angelo
    Toorawa, Robert
    Lee, Christopher
    DIABETES, 2016, 65 : A292 - A292
  • [30] Assessment of empagliflozin add-on therapy to metformin and glimepiride in patients with inadequately controlled type-2 diabetes mellitus
    Jawed, Bilal
    Ahmed, Shadab
    Abbas, Syed Qamar
    Ahmed, Zeeshan
    Andleeb, Shomaiza
    Ahmad, Salman Ashfaq
    Asif, Muhammad
    Akhter, Erum
    Ahmed, Salman
    Hussain, Muhammad Waleed
    Iqbal, Adnan
    Ishaqui, Azfar Athar
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 35 (06) : 1733 - 1738
12345